Philips launches image-guided neurology surgical tech in Europe

Philips Healthcare's NeuroSuite-Courtesy of Philips

At the Live Interventional Neuroradiology & Neurosurgery Course in Paris, Philips Healthcare ($PHG) launched a new device, the NeuroSuite, for minimally invasive image guided neurological surgeries for patients with ailments like ischemic stroke or large neck aneurysm.

The company says the new product's advantages include a lower X-ray dose and real-time 3D imaging. 

"In image-guided interventions the ultimate goal is to see clearly and navigate effectively, while managing X-ray dose for patients, staff and clinicians," said Ronald Tabaksblat, Philip's general manager of the interventional X-ray division. "Developed in collaboration with clinical partners around the world, Philips NeuroSuite has been designed for that purpose and underpins Philips' global leadership position in live-image guidance technologies."

Philips said in the statement that the first NeuroSuite system was installed in Kaolinksa University Hospital in Stockholm, Sweden, which the company described as a "center of excellence for stroke treatment." 

"Philips' latest innovation is NeuroSuite with a new 20 inch detector on the frontal plane, providing superb 3D-images and big enough for spine imaging. On the lateral plane, the new 15 inch detector brings visualization of the complete cerebral vasculature, with reduced collision risks and enhanced projection freedom," said Dr. Michael SAderman of the hospital's department of neuroradiology.

The NeuroSuite is not available in the U.S.

- read the release

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.